19-7145363-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.2268-2273G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.4 in 151,716 control chromosomes in the GnomAD database, including 13,423 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 13423 hom., cov: 32)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.819

Publications

12 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.2268-2273G>A intron_variant Intron 11 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.2232-2273G>A intron_variant Intron 10 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.2268-2273G>A intron_variant Intron 11 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.2232-2273G>A intron_variant Intron 10 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.2268-2273G>A intron_variant Intron 11 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.2232-2273G>A intron_variant Intron 10 of 20 1 ENSP00000342838.4 P06213-2

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60744
AN:
151596
Hom.:
13423
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.244
Gnomad AMI
AF:
0.622
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.415
Gnomad EAS
AF:
0.0878
Gnomad SAS
AF:
0.465
Gnomad FIN
AF:
0.501
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.506
Gnomad OTH
AF:
0.406
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.400
AC:
60755
AN:
151716
Hom.:
13423
Cov.:
32
AF XY:
0.397
AC XY:
29454
AN XY:
74116
show subpopulations
African (AFR)
AF:
0.243
AC:
10055
AN:
41350
American (AMR)
AF:
0.355
AC:
5402
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.415
AC:
1438
AN:
3464
East Asian (EAS)
AF:
0.0874
AC:
452
AN:
5172
South Asian (SAS)
AF:
0.466
AC:
2248
AN:
4822
European-Finnish (FIN)
AF:
0.501
AC:
5255
AN:
10482
Middle Eastern (MID)
AF:
0.497
AC:
145
AN:
292
European-Non Finnish (NFE)
AF:
0.506
AC:
34337
AN:
67892
Other (OTH)
AF:
0.407
AC:
856
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1782
3564
5345
7127
8909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.472
Hom.:
30844
Bravo
AF:
0.381
Asia WGS
AF:
0.319
AC:
1109
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.039
DANN
Benign
0.83
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8103483; hg19: chr19-7145374; API